Spire Wealth Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
Spire Wealth Management's AVXL Position: Q3 2026 in Review
Spire Wealth Management held its Anavex Life Sciences (AVXL) position steady in Q3 2026 at 2,645 shares worth $5.34K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.
Spire Wealth Management first reported a position in AVXL in Q1 2021 and has held it in 23 quarters since. The position peaked at $60K in Q2 2021. 74 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.
- Spire Wealth Management held 2,645 shares of Anavex Life Sciences worth $5.34K as of Q3 2026.
- Spire Wealth Management left its Anavex Life Sciences share count unchanged in Q3 2026.
- Anavex Life Sciences made up ﹤0.01% of Spire Wealth Management's portfolio in Q3 2026, its #1792 holding.
- Spire Wealth Management first reported a position in Anavex Life Sciences in Q1 2021 and has held it in 23 quarters since.
- Spire Wealth Management's Anavex Life Sciences position peaked at $60K in Q2 2021.
- 74 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.
Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.